R
Radiopharm Theranostics Ltd
ASX:RAD
Radiopharm Theranostics Ltd
ASX:RAD
Price:
0.021
AUD
Market Closed
Market Cap:
AU$74.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
Ensurance Ltd
ASX:ENA
|
AU |
|
Adways Inc
TSE:2489
|
JP |
|
Sparta AG
F:SPT6
|
DE |
|
T
|
TimkenSteel Corp
NYSE:MTUS
|
US |
|
O
|
Odlewnie Polskie SA
WSE:ODL
|
PL |
|
Imperial Brands PLC
LSE:IMB
|
UK |
|
B
|
Brack Capital Properties NV
TASE:BCNV
|
NL |
|
E
|
Eco's Co Ltd
TSE:7520
|
JP |
|
T
|
Teo Seng Capital Bhd
KLSE:TEOSENG
|
MY |
|
Upergy
PAR:ALUPG
|
FR |
|
A
|
Adamant Holding Inc
CNSX:ADMT
|
CA |
|
V
|
Vietnam National Reinsurance Corp
VN:VNR
|
VN |
|
Aisan Industry Co Ltd
TSE:7283
|
JP |
|
A
|
Ahlada Engineers Ltd
NSE:AHLADA
|
IN |
|
Titagarh Wagons Ltd
NSE:TWL
|
IN |
|
R
|
Regina Miracle International (Holdings) Ltd
HKEX:2199
|
HK |
|
P
|
Public Storage
LSE:0KS3
|
US |
|
W
|
Woori Technology Investment Co Ltd
KOSDAQ:041190
|
KR |
|
Ashinskiy Metzavod PAO
MOEX:AMEZ
|
RU |
|
BRT Apartments Corp
NYSE:BRT
|
US |
|
Nedap NV
F:NE3
|
NL |
|
H
|
Hiroca Holdings Ltd
TWSE:1338
|
CN |
|
RS Group PLC
LSE:RS1
|
UK |
Multiples-Based Value
The Multiples-Based Value of one RAD stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.021 AUD, Radiopharm Theranostics Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RAD Multiples-Based Value
LOCKED
Multiples Across Competitors
RAD Competitors Multiples
Radiopharm Theranostics Ltd Competitors
Radiopharm Theranostics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
74.4m AUD | 20.5 | -1.7 | -1 | -1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
365.4B USD | 6 | 87.3 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
184.6B USD | 5 | 23.9 | 13.9 | 13.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.9B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.3B USD | 9.2 | 27.9 | 20.9 | 21.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.7B USD | 5.6 | 17.9 | 13.4 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3 | 33.2 | 11.2 | 14 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.2 | 35.9 | 39 | 39.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
